Ilsung Co. Ltd. (003120) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ilsung Co. Ltd. (003120:KRX), powered by AI.

Current Price
₩20,000
P/E Ratio
228.2
Market Cap
266.0B
Sector
Healthcare
What is the Ilsung Co. Ltd. stock price forecast?

Ilsung Co. Ltd. is currently trading at ₩20,000. View real-time AI analysis on Alpha Lenz.

What is Ilsung Co. Ltd. insider trading activity?

View the latest insider trading data for Ilsung Co. Ltd. on Alpha Lenz.

What is Ilsung Co. Ltd.'s P/E ratio?

Ilsung Co. Ltd.'s P/E ratio is 228.2.

Ilsung Co. Ltd.

KRX · 003120
₩20,000+30(+0.15%)Market closedKRX regular session 09:00–15:30 KST
Ask about Ilsung Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Ilsung Co. Ltd. trades at a P/E of 228.2 (premium valuation) with modest ROE of 0.3%.

Ask for details

Company Overview

Ilsung Co. Ltd. is a prominent player in the construction industry, specializing in civil engineering and building services. Established with the goal of enhancing infrastructure, Ilsung Co. Ltd. focuses on large-scale projects that include residential complexes, commercial facilities, and public infrastructure developments such as roads and bridges. The company is known for its expertise in managing complex engineering challenges and implementing innovative construction techniques. Operating primarily in South Korea, Ilsung Co. Ltd. contributes significantly to the country’s urban development and industrial expansion. The company plays a crucial role in underpinning the economic growth of regions by providing reliable construction solutions. Through its commitment to quality and sustainable practices, Ilsung Co. Ltd. maintains a strong reputation in the construction sector, impacting real estate markets and associated industries.

CEO윤석근, 엄대식, 윤종호(각자대표)
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

₩266,000,000,000Market Cap
₩64,291,702,800Revenue
13.30MShares Out
0Employees

Margins

43.37%Gross
25.53%EBITDA
-9.58%Operating
4.40%Pre-Tax
1.81%Net

Valuation

228.16P/E
0.69P/B
4.14EV/Sales
8.89EV/EBITDA
155.96P/FCF

Growth (CAGR)

1.63%Rev 3Yr
9.63%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
-77.94%Net Inc 3Yr
-18.39%Net Inc 5Yr

Returns

0.29%ROA
0.30%ROE
0.72%ROIC

Financial Health

₩120,279,901,110Cash & Cash Equivalents
₩-103,614,662,540Net Debt
4.31%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Ilsung Co. Ltd. (ticker: 003120) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $266.0B.

The current price is ₩20,000 with a P/E ratio of 228.16x and P/B of 0.69x.

ROE is 0.30% and operating margin is -9.58%. Annual revenue is $64.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Ilsung Co. Ltd. (003120) Stock Forecast 2026 ₩20,000 — Price, Financials & Analyst Targets | Alpha Lenz